Chemoinformaics analysis of 1-Alpha,5-Alpha-Epoxy-Alpha-Guaiene
| Molecular Weight | 220.356 | nRot | 1 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 14 |
| Exact Molecular Weight | 220.183 | nRing | 3 |
| Solubility: LogS | -4.787 | nHRing | 1 |
| Solubility: LogP | 4.275 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 0 | BPOL | 25.813 |
| QED | 0.482 |
| Synth | 4.551 |
| Natural Product Likeliness | 2.623 |
| NR-PPAR-gamma | 0.075 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.552 |
| MDCK | 0.0000266 |
| BBB | 0.792 |
| PPB | 0.881778 |
| VDSS | 1.802 |
| FU | 0.0708539 |
| CYP1A2-inh | 0.118 |
| CYP1A2-sub | 0.646 |
| CYP2c19-inh | 0.114 |
| CYP2c19-sub | 0.953 |
| CYP2c9-inh | 0.115 |
| CYP2c9-sub | 0.548 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.917 |
| CYP3a4-inh | 0.185 |
| CYP3a4-sub | 0.523 |
| CL | 17.366 |
| T12 | 0.095 |
| hERG | 0.056 |
| Ames | 0.034 |
| ROA | 0.175 |
| SkinSen | 0.272 |
| Carcinogencity | 0.781 |
| EI | 0.081 |
| Respiratory | 0.95 |
| NR-Aromatase | 0.209 |
| Antiviral | Yes |
| Prediction | 0.866098 |